Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Expert Opinion on Drug Safety
|
December 9, 2009
Rechallenge in drug-induced liver injury: the attractive hazard
Raúl J Andrade, Mercedes Robles, María Isabel Lucena
Expert Opinion on Drug Metabolism & Toxicology
|
January 29, 2016
"Drug-Induced Liver Injury Clinical Consortia: a global research response for a worldwide health challenge"
Raúl J Andrade, Aida Ortega-Alonso, María Isabel Lucena
Alimentary Pharmacology & Therapeutics
|
January 28, 2020
Systematic review: ibuprofen-induced liver injury
Miguel E Zoubek, María Isabel Lucena, Raúl J Andrade, et al.
Medicina Clinica
|
April 18, 2002
[Tetrabamate and a benefit-risk ratio]
María Isabel Lucena, Raúl J Andrade, Elena García-Ruiz, et al.
Revista Espanola De Enfermedades Digestivas
|
September 29, 2011
Hepatotoxicity in 2011--advancing resolutely
Marta Lozano-Lanagrán, Mercedes Robles, María Isabel Lucena, et al.
Medicina Clinica
|
May 16, 2003
[Acute hepatitis due to bentazepam]
Raúl J Andrade, Enrique López-Torres, María Isabel Lucena, et al.
Cancers
|
November 11, 2022
Recreational Drugs and the Risk of Hepatocellular Carcinoma
José M Pinazo-Bandera, Miren García-Cortés, Antonio Segovia-Zafra, et al.
The American Journal of Gastroenterology
|
July 24, 2002
Chronic hepatitis C, ibuprofen, and liver damage
Raúl J Andrade, María Isabel Lucena, Miren García-Cortés, et al.
Genes
|
July 27, 2022
Identification of New Toxicity Mechanisms in Drug-Induced Liver Injury through Systems Pharmacology
Aurelio A Moya-García, Andrés González-Jiménez, Fernando Moreno, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
April 9, 2011
Assessment of nonsteroidal anti-inflammatory drug-induced hepatotoxicity
José Ag Agúndez, María Isabel Lucena, Carmen Martínez, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Expert Opinion on Drug Safety
|
December 9, 2009
Rechallenge in drug-induced liver injury: the attractive hazard
Raúl J Andrade, Mercedes Robles, María Isabel Lucena
Expert Opinion on Drug Metabolism & Toxicology
|
January 29, 2016
"Drug-Induced Liver Injury Clinical Consortia: a global research response for a worldwide health challenge"
Raúl J Andrade, Aida Ortega-Alonso, María Isabel Lucena
Alimentary Pharmacology & Therapeutics
|
January 28, 2020
Systematic review: ibuprofen-induced liver injury
Miguel E Zoubek, María Isabel Lucena, Raúl J Andrade, et al.
Medicina Clinica
|
April 18, 2002
[Tetrabamate and a benefit-risk ratio]
María Isabel Lucena, Raúl J Andrade, Elena García-Ruiz, et al.
Revista Espanola De Enfermedades Digestivas
|
September 29, 2011
Hepatotoxicity in 2011--advancing resolutely
Marta Lozano-Lanagrán, Mercedes Robles, María Isabel Lucena, et al.
Medicina Clinica
|
May 16, 2003
[Acute hepatitis due to bentazepam]
Raúl J Andrade, Enrique López-Torres, María Isabel Lucena, et al.
Cancers
|
November 11, 2022
Recreational Drugs and the Risk of Hepatocellular Carcinoma
José M Pinazo-Bandera, Miren García-Cortés, Antonio Segovia-Zafra, et al.
The American Journal of Gastroenterology
|
July 24, 2002
Chronic hepatitis C, ibuprofen, and liver damage
Raúl J Andrade, María Isabel Lucena, Miren García-Cortés, et al.
Genes
|
July 27, 2022
Identification of New Toxicity Mechanisms in Drug-Induced Liver Injury through Systems Pharmacology
Aurelio A Moya-García, Andrés González-Jiménez, Fernando Moreno, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
April 9, 2011
Assessment of nonsteroidal anti-inflammatory drug-induced hepatotoxicity
José Ag Agúndez, María Isabel Lucena, Carmen Martínez, et al.
Page
of 2